Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

2 More Drugs Named in Meningitis Outbreak

The same compounding center made them, too

By Neal Colgrass,  Newser Staff

Posted Oct 15, 2012 2:33 PM CDT

(Newser) – Federal health officials today implicated two more drugs in the meningitis outbreak that has killed 15 people and sickened at least 214, NBC News reports. One is a steroid called triamcinolone acetonide, which is similar to methylprednisolone acetate, the back pain steroid that officials have already linked to the outbreak. The other is a cardioplegic solution used during open heart surgery.

Both are distributed by the New England Compounding Center, the same pharmacy that produced the original steroids suspected of causing the outbreak. So the FDA is advising people to be careful of any injectable NECC drugs, including those used for the eyes or during eye surgery, as well as any cardioplegic solutions. "Patients who received these products should be alerted to the potential risk of infection," the FDA said in a statement.

A sign requesting No Soliciting hangs on the door of the New England Compounding Center, the pharmacy that distributed drugs linked to an outbreak of fungal meningitis, in Framingham, Mass.
A sign requesting "No Soliciting" hangs on the door of the New England Compounding Center, the pharmacy that distributed drugs linked to an outbreak of fungal meningitis, in Framingham, Mass.   (AP Photo/Stephan Savoia, File)
« Prev« Prev | Next »Next » Slideshow
My TakeCLICK BELOW TO VOTE
3%
1%
5%
1%
86%
4%
To report an error on this story, notify our editors.
COMMENTS
Showing 3 of 3 comments
Linmarvan
Oct 25, 2012 3:21 PM CDT
The FDA did develop a clear set of rules for compounding, but subsequent litigation culminated in a Supreme Court decision in 2002 that struck them down.   THOMPSON V. WESTERN STATES MEDICAL CENTER (01-344) 535 U. S. 357   The problem is NOT deregulation. The FDA has never had authority over the compounders.  They are overseen by state pharmacy boards with different levels of authority. The problem is a total lack of regulation at the federal level.  Since these firms do not manufacture the drugs, they do not fall under the FDA's purview and never have. This is a completely different issue from deregulation.
HANKHILL
Oct 16, 2012 10:37 AM CDT
two more drugs named- mitt and obambam?
extremenewsjunkie
Oct 15, 2012 2:54 PM CDT
Republicans want to eliminate regulations that protect people.
 

NEWS FROM OUR PARTNERS
Other Sites We Like:   24/7 Wall St.   |   BuzzFeed   |   Cracked   |   Timelines   |   POPSUGAR Tech   |   Business Insider   |   HuffPost Entertainment   |   NewsOne